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Introduction: Video capsule endoscopy (VCE) has been proposed as an alternative triaging tool 
for diagnosis of hematemesis and non-hematemesis (GIB). Randomized controlled trials have 
shown higher detection rates of bleeding with VCE when used as the first procedure compared 
with standard of care (SOC). This approach has been shown to be safe, and well tolerated. VCE 
is particularly suitable for the diagnosis of GIB in suspected/established SARS-CoV-2 (COVID) 
patients as it requires minimal patient contact (one staff person) to set up, and it avoids 
aerosolization and sedation. We used VCE as the first diagnostic modality in hemodynamically 
stable patients with GIB. Here we report the outcomes of the first 50 patients undergoing VCE in 
the COVID era as compared to 57 historical controls in the pre-COVID era.  
Methods: Hemodynamically stable patients with suspected GIB/severe anemia admitted to our 
hospital between March and May 2020 and who underwent VCE as the first line diagnostic 
modality composed the experimental group. Demographic, clinical, and outcome data was 
collected and analyzed. The control group comprised of patients undergoing evaluation for GIB 
by SOC at our hospital in January 2020. Continuous variables were compared using Student t-
test. Categorical variables were compared using Fisher’s exact test.  
Results: Patients in both groups had similar baseline characteristics. More patients in the COVID 
cohort presented with melena and fewer presented with hematochezia as their manifestation of 
their GIB. This difference was only significant for hematochezia. Bleeding could be localized in 38 
(76%) of the COVID cohort patients as compared to 36 (63%) of the historical controls using the 
first diagnostic modality, p>0.05 significant. Only 22 (44%) of the VCE patients underwent 
additional invasive diagnostic/therapeutic maneuvers and the majority were spared more invasive 
testing. Only 13 (26%) of the VCE patients, as compared to 47 (82%) of the historical controls 
underwent upper endoscopy for evaluation of GIB. There was no significant difference in 
transfusion requirements, degree of hemoglobin drop, in-hospital mortality, re-admission or 
rebleeding rates between the two groups.  
Conclusion: VCE appears to be a safe alternative to traditional diagnostic evaluation of GIB in 
the era of COVID. It reduced risk of exposure of staff to endoscopic aerosols, conserved personal 
protective equipment and reduced staff utilization.  
  
Table 1- Baseline characteristics   
  covid Pre-covid p- value 
n 50 57  
Male 30 (60) 36 (63) 0.77 
Average Age 68 +/- 14.3 61.8+/-14.5 0.03 
Developed GI bleed in the 
hospital 17 (34) 18 (32) 0.76 
Race    
Caucasian 34 (68) 39 (68) 0.82 
African American 6 (12) 4 (7)  
Hispanic  3 (6) 4 (7)  
Asian  1 (2) 0 (0)  
other 6 (12) 10 (18)  
Comorbidities       
COPD 10 (20) 11 (19) 0.71 
CHF 17 (34) 9 (16) 0.07 
CAD 22 (44) 19 (33) 0.4 
Cirrhosis 8 (16) 16 (28) 0.21 
ESRD 5 (10) 4 (7) 0.86 
Severe Aortic stenosis 1 (2) 1 (2) 1 
Diabetes 19 (38) 19 (33) 0.99 
ASA class       
1 1 (2) 1 (2)  
2 7 (14) 4 (7)  
3 31 (62) 37 (65)  
4 11 (22) 15 (26)  
NSAID use 4 (8) 9 (16) 0.28 
Aspirin 27 (54) 19 (33) 0.09 
P2Y12 7 (14) 5 (9) 0.72 
Coumadin/heparin 11 (22) 9 (16)  
Direct oral anticoagulants 9 (18) 3 (5)  
No anticoagulation 17 (34) 33 (58)  
Baseline HGB (g/dl) 10.6 +/-2.1 11.4 +/- 2.4 0.12 
Lowest HGB (g/dl) 6.9 +-1.9 7.5 +/-1.9 0.12 
HGB drop (g/dl) 3.7+/-1.2 3.8 +/- 2.3 0.75 
BUN/cr>20 34 (66) 34 (60)  
INR>2 10 (20) 4 (7) 0.09 
Presenting symptom     
Hematemesis 5 (10) 9 (16) 0.49 
Melena 31 (62) 25 (44) 0.13 
Hematochezia 2 (4) 10 (18) 0.03 
Anemia 12 (24) 13 (23) 0.73 
  
Table 2- outcomes    
First test covid Pre-covid p-value 
EGD 0 (0) 47 (82) <0.001 
Colonoscopy 0 (0) 7 (12) <0.001 
Capsule 50 (100) 3 (5) <0.001 
Bleeding localization on first test 38 (76) 36 (63) 0.2 
Bleeding localization at the end 39 (76) 41 (72) 0.45 
Needing any invasive procedures 22 (44) 55 (96)  <0.001 
Capsule only 29 (58) 2 (4) <0.001 
Blood transfusion (units) 2.7+/-3.6 2.5 +/-2.6 0.8 
Number of invasive procedures       
1 17 (34) 44 (77) <0.001 
2 2 (4) 12 (21) 0.01 
3 2 (4) 1 (2) 0.86 
4 0 (0) 0 (0) 1 
5 1 (2) 0 (0) 1 
Additional procedures needed       
EGD 13 (26) 1 (2)  <0.001 
Colonoscopy 7 (14) 7 (12) 1 
VCE 2 (4) 3 (5) 0.75 
Enteroscopy 5 (10) 1 (2) 0.1 
CT angiogram 0 (0) 0 (0) 1 
IR 0 (0) 0 (0) 1 
Surgery 1 (2) 0 (0) 0.86 
Total EGD 13 (26) 47 (82) <0.01 
Total Colonoscopy 7 (14) 14 (25) 0.22 
Video capsule Safety       
Gastric evacuation time (hh:min) 1:09 +/- 0:09   
Gastric evac > 1h 15 (30)   
Capsule entered colon 42 (84)   
KUB needed 6 (12)   
Complication       
In hospital mortality 2 (4) 2 (4) 1 
GI bleed mortality 0 (0) 0 (0) 1 
Rebleeding 7 (14) 9 (16) 0.71 
Re-admission for bleeding 5 (10) 5 (9) 1 
Bowel obstruction 0 (0)   
Bowel perforation 0 (0)   
Capsule aspiration 0 (0)   
Capsule retention 3 (6)   
 
